最新消息

SINGAPORE: HSA INTRODUCED SUBMISSION WINDOW FOR REGISTRATION SUPPORT INITIATIVE OF UNREGISTERED MEDICAL DEVICES – September/October 2026

SINGAPORE: HSA INTRODUCED SUBMISSION WINDOW FOR REGISTRATION SUPPORT INITIATIVE OF UNREGISTERED MEDICAL DEVICES – September/October 2026

  • 2026-10-27 05:15:40

Singapore's Health Sciences Authority (HSA) has introduced the submission window for the inaugural year of the Registration Support Initiative for unregistered medical device previously have been accessed through Special Access Routes (SAR) to 31 December 2026. This provides medical and dental practitioners and other stakeholders with additional time to prepare submissions, engage relevant parties and obtain the necessary endorsements. From 2027 onwards, the Initiative will follow a standard annual submission cycle from 1 October to 31 December.

了解更多
SINGAPORE: HSA PUBLISHES FINALISED GL-10 R1 BEST PRACTICES GUIDE ON MEDICAL DEVICE CYBERSECURITY – September/October 2026

SINGAPORE: HSA PUBLISHES FINALISED GL-10 R1 BEST PRACTICES GUIDE ON MEDICAL DEVICE CYBERSECURITY – September/October 2026

  • 2026-10-27 04:39:09

Singapore's Health Sciences Authority (HSA) has published the finalised GL-10 R1 Best Practices Guide on Medical Device Cybersecurity following a public consultation conducted from 10 March to 13 May 2025. The guide provides best practice recommendations and considerations for managing cybersecurity risks associated with connected medical devices throughout the Total Product Life Cycle (TPLC). HSA also published a summary of responses to stakeholder feedback received during the consultation.

了解更多
Singapore: HSA Allows Concurrent Processing of Up to Two Change Notification Applications for the Same Medical Device Listing – August/September 2026

Singapore: HSA Allows Concurrent Processing of Up to Two Change Notification Applications for the Same Medical Device Listing – August/September 2026

  • 2026-09-21 03:40:18

Singapore's Health Sciences Authority (HSA) has enhanced its Change Notification (CN) process for registered medical devices. With immediate effect, up to two CN applications may now be processed concurrently for the same medical device listing, providing greater flexibility for stakeholders in managing regulatory changes and facilitating more timely implementation of device updates.

了解更多
SINGAPORE: HSA REGULATORY UPDATES FOR MEDICAL DEVICES AND IVDS – May/June 2026

SINGAPORE: HSA REGULATORY UPDATES FOR MEDICAL DEVICES AND IVDS – May/June 2026

  • 2026-06-26 06:09:06

On 20 May 2026, HSA held a virtual industry briefing to present regulatory updates and support initiatives for medical devices and in vitro diagnostics (IVDs). The session covered revised guidance for software medical devices, updated Artificial Intelligence in Healthcare Guidelines (AIHGle 2.0), audit reporting requirements, regulatory reliance with Malaysia's Medical Device Authority (MDA), reclassification of COVID‑19 IVDs, restructuring of IVD cluster grouping and a registration support initiative for unregistered devices.

了解更多
SINGAPORE: HSA ATTAINS HIGHEST LEVEL RECOGNITION FROM WHO FOR MEDICAL DEVICE REGULATORY SYSTEM – March/April 2026

SINGAPORE: HSA ATTAINS HIGHEST LEVEL RECOGNITION FROM WHO FOR MEDICAL DEVICE REGULATORY SYSTEM – March/April 2026

  • 2026-04-23 09:11:50

Singapore's Health Sciences Authority (HSA) has achieved the World Health Organization (WHO) Maturity Level 4 for medical device regulatory systems, the highest classification under WHO's global benchmarking framework. The recognition, announced on 10 March 2026 during the International Medical Device Regulators Forum (IMDRF) 29th session in Singapore, strengthens Singapore's position in global medical device regulation as a trusted reference authority for other regulators.

了解更多
SINGAPORE:  Streamlining Medical Device Approval in Asia: Singapore HSA is Recognized as Reference Country by Hong Kong MDD – June/July 2024

SINGAPORE: Streamlining Medical Device Approval in Asia: Singapore HSA is Recognized as Reference Country by Hong Kong MDD – June/July 2024

  • 2024-06-20 05:49:36

In a significant step towards regional harmonization, the Hong Kong MDD announced on 2 April 2024, that they now recognize marketing approvals for Class II, III, and IV medical devices issued by Singapore's Health Sciences Authority (HSA) This means manufacturers with existing HSA approvals can now use them to support their applications for registration in Hong Kong, potentially saving significant time and resources.

了解更多
SINGAPORE: HSA IS RECOGNIZED BY WHO AS STRINGENT REGULATORY AUTHORITY (SRA) FOR CLASS C AND D IN VITRO DIAGNOSTIC MEDICAL DEVICES (IVD) - JULY/AUGUST 2023

SINGAPORE: HSA IS RECOGNIZED BY WHO AS STRINGENT REGULATORY AUTHORITY (SRA) FOR CLASS C AND D IN VITRO DIAGNOSTIC MEDICAL DEVICES (IVD) - JULY/AUGUST 2023

  • 2023-07-21 02:32:25

Singapore's Health Science Authority (HSA) is pleased to announce their status as a recognized Stringent Regulatory Authority (SRA) for Class C and D IVD by WHO. The SRA status means high-risk IVD products registered with HSA might obtain faster evaluation through WHO prequalification assessment, enabling manufacturers accelerated access to global markets.

了解更多